ノイルイミューン・バイオテック(株)【4893】の掲示板 2024/02/29〜

Takeda to Present Oncology Portfolio and Pipeline Data at the 2024 ASCO Annual Meeting

POSTER PRESENTATION Developmental Therapeutics— Immunotherapy Saturday, June 1, 2024 9:00 AM–12:00 PM CDT Location: Hall A

Updated results from first-in-human Phase 1 doseescalation trial of TAK-102, a GPC3-targeted armored CAR T cells, in patients with advanced solid tumors
ーーーーーーーーーーーーーー
Koji Tamadaも行くみたいですが、接待旅行でしょうね